Score Your Stock

US stock · figures in US dollars · scored on full-year results

Centene Centene Corporation Common Stock

CNC · Healthcare · Healthcare Plans
Bottom 18% of scored stocks
OkayBottom 18% of scored stocks
Weak SpotRecent Loss

Centene scores 42/100 on fundamentals: in the bottom 18% of 503 scored S&P 500 stocks. Its strongest area is Cash & Dividends (63/100); its weakest is Price Fairness (17/100). It carries 2 warning flags: Weak Spot, Recent Loss.

Best
Cash 63
Weakest
Price 17
  • Carries a Weak Spot flag
  • Carries a Recent Loss flag

An expensively priced stock, but price fairness needs attention.

What looks good
What to watch
Mkt capUS$ 33.6b#305 of 503 in the S&P 500EPSUS$ 2.91P/E23.2×✓ vs sector median 30.5×P/B1.5×✓ vs sector median 4×Div yieldNo dividends paidBottom 15% in the S&P 50052w range · 89% of range31.6372.50
as of 31 Oct 2026

Nearby peers

Ranks #47 of 60 in Healthcare by score

#1Universal Health Services79#45Abbott Laboratories44#46Merck &43
#47Centene42
#48IQVIA42#49Elevance Health41

One-Minute Summary

Why Centene scores 42

An expensively priced stock, but price fairness needs attention.

What looks good
What to watch

Business Strength

20
Why 20?
Pillar score: (0 + 2 + 0 + 0 + 0) = 2 of 10 points → 20
Return on Equity (ROE)7%Weak4-Year Revenue Growth+10%/yrStrong4-Year Profit Growthn/m (loss-making)WeakNet Profit Margin1%WeakQuarterly Momentumn/m (loss-making)Weak
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -46%Equity ↓ -14.1%ROE % 6.6%
Net ProfitEquityROE %
2.7b3.3b-6.7b1.5b25.8b26.4b20.0b22.2b202320242025TTM10.5%12.5%-33.4%6.6%

Revenue & Net Profit, with Net Margin

Revenue ↑ +32.4%Net Profit ↓ -46%Net Margin % 0.7%
RevenueNet ProfitNet Margin %
154.0b163.1b194.8b203.9b2.7b3.3b-6.7b1.5b202320242025TTM1.8%2%-3.4%0.7%

Sales grew about 32.4% over 4 years: customers keep spending more with this company.

The company lost money in recent years: the bars below zero are losses, not profits.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +27.5%Net Profit ↑ +53%Net Margin % 2%
RevenueNet ProfitNet Margin %
42.0b40.8b46.6b48.7b49.7b49.7b49.9b53.6b713m283m1.3b-253m-6.6b-1.1b1.5b1.1bQ3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'261.7%0.7%2.8%-0.5%-13.3%-2.2%3.1%2%
▲▲▲▼▼▼▲▲

Sales grew about 27.5% over the last 8 quarters: customers keep spending more with this company.

The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.

Why 50?
Pillar score: (1 + 1 + 1) = 3 of 6 points → 50
Debt-to-Equity0.7×OkayCurrent Ratio1.2×OkayInterest Coverage4×Okay
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↓ -17.7%Equity ↓ -14.1%D/E 0.7×
Total DebtEquityD/E
18.9b19.4b18.2b15.5b25.8b26.4b20.0b22.2b202320242025TTM0.7×0.7×0.9×0.7×

Borrowings fell about 17.7% over 4 years: the company is steadily getting safer.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +11.5%Current Liabilities ↑ +6.4%Current Ratio 1.2×
Current AssetsCurrent LiabilitiesCurrent Ratio
40.8b38.0b40.4b45.5b36.7b34.3b36.7b39.1b202320242025TTM1.1×1.1×1.1×1.2×
Why 63?
Pillar score: (0 + 1 + 2 + 2) = 5 of 8 points → 63
Dividend QualityNo dividends paidWeak
Payout ratio: 0%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowPositive & growingStrongCash & Cash EquivalentsGrowing & covers near-term debtStrong
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↓ -41.3%Free CF ↓ -45.6%
Operating CFFree CF
8.1b154m5.1b4.7b7.3b-490m4.3b3.9b202320242025TTM

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↑ +20.4%Short-Term Debt ↓ -26.1%Total Debt ↓ -17.7%
CashShort-Term DebtTotal Debt
17.2b14.1b17.9b20.7b119m110m50m88m18.9b19.4b18.2b15.5b202320242025TTM

Dividends per Share, with Yield

DPS (cents) → +0%Yield % 0%
DPS (cents)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 17?
Pillar score: (0 + 1 + 0) = 1 of 6 points → 17
P/E Ratio23.2×WeakP/B Ratio1.5×OkayPEG Ration/m (growth not measurable)Weak
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 70.17US$ 51.09US$ 32.00Oct '25Feb '26Jun '26Oct '26

The share price is up about 93.5% over the past year.

Why 60?
Pillar score: (0 + 2 + 2 + 2 + 0) = 6 of 10 points → 60 · 1 N/A skipped
Earnings ConsistencyVery bumpyWeakDebt Trend (4yr)FallingStrongShare Count Trend (4yr)-3%/yrStrongAsset Turnover Trend (4yr)+41.4%StrongQuarterly ConsistencyLoss in 3 of 8 quartersWeak

No data: Inventory vs Sales (4yr)

Ranks #47 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#45Abbott Laboratories44#46Merck &43
#47Centene (you)42
#48IQVIA42#49Elevance Health41

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 203.9bUS$ 1.5bUS$ 4.7bUS$ 3.9bUS$ -781.0mUS$ 20.7bUS$ 15.5bUS$ 88.0mUS$ 22.2bUS$ 45.5bUS$ 39.1bUS$ 79.3bUS$ 57.0b-7%1%0.7×1.2×4.0×----
2025US$ 194.8bUS$ -6.7bUS$ 5.1bUS$ 4.3bUS$ -767.0mUS$ 17.9bUS$ 18.2bUS$ 50.0mUS$ 20.0bUS$ 40.4bUS$ 36.7bUS$ 76.7bUS$ 56.7bUS$ 0.0m-33%-3%0.9×1.1×-8.9×0%-3.1×1.0×-
2024US$ 163.1bUS$ 3.3bUS$ 154.0mUS$ -490.0mUS$ -644.0mUS$ 14.1bUS$ 19.4bUS$ 110.0mUS$ 26.4bUS$ 38.0bUS$ 34.3bUS$ 82.4bUS$ 55.9bUS$ 0.0m13%2%0.7×1.1×7.1×0%9.2×1.2×0.3
2023US$ 154.0bUS$ 2.7bUS$ 8.1bUS$ 7.3bUS$ -799.0mUS$ 17.2bUS$ 18.9bUS$ 119.0mUS$ 25.8bUS$ 40.8bUS$ 36.7bUS$ 84.6bUS$ 58.7bUS$ 0.0m10%2%0.7×1.1×6.0×0%14.7×1.5×1.0